Delivery Order SPE2DB22D3010-SPE2DB25FP3QE
- Not listed
- The Defense Logistics Agency awarded a Delivery Order valued at $5,542.08 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on July 24, 2025, with an ultimate completion date of August 14, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,313.12 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count packaging) on September 2, 2025, with completion targeted for September 23, 2025. This firm fixed-price, non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30-count units, with a contract ceiling value of $4,156.56 and an ultimate completion date of October 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania facility. The award represents a child contract under...
- The Defense Logistics Agency awarded a $1,385.52 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Orgovyx 120 mg, with an ultimate completion date of August 11, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The work will be performed at the contractor's corporate office in Conshohocken, Pennsylvania, supporting federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-unit pack) on August 27, 2025, with an ultimate completion date of September 18, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded contract for pharmaceutical procurement supporting federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $4,156.56 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, and represents a non-set-aside, competitively awarded contract. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units, with a ceiling value of $1,385.52 and completion date of July 10, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX, which...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,771.04 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-unit packaging) with a firm fixed price structure. The contract is non-competitive and competitively awarded with an ultimate completion date of July 16, 2025. AmerisourceBergen's corporate office, located in Conshohocken, Pennsylvania, serves as both the place of performance and the point of delivery for this pharmaceutical product. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for 30 tablets of Orgovyx 120 mg with a ceiling value of $4,156.56 and a completion date of October 14, 2025. This competitively awarded, firm fixed price delivery order represents a non-set-aside procurement under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at the vendor's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for 30-tablet units of Orgovyx 120 mg, a pharmaceutical product, with performance at the contractor's Conshohocken, Pennsylvania location. The award was made on August 21, 2025, under firm fixed-price terms with an ultimate completion date of September 12, 2025. This delivery order was competitively awarded with no set-aside designation and represents a child contract under...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB25FP3QEDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,771.04 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) under a firm fixed-price contract. The award was made on September 24, 2025, with an ultimate completion date of October 16, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total ceiling value of $999,999,999.00 and extends through December 2026. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The SPE2DX IDC vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for Orgovyx, a hormone treatment medication, exemplifies the company's role in fulfilling specialized pharmaceutical needs across the federal medical supply chain through its flexible and expansive contract arrangement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 9/24/25 |